Home    MASTER 2015    Network    Members    Contact   









Newsletter?

Click here!

News

19.10.10 16:00

FDA approves Botulinumtoxin (Botox / Allergan) for Headache Prophylaxis in Chronic Migraine

Again the indication list of Botulinumtoxin A has been increased....

The very powerful neuro toxin Botulinumtoxin A has found its way into the public by its use in Aesthetic Medicine to treat all kind of folds. The first approval by the FDA 21 years ago was for blepharospasm. Later followed the glabella folds and severe underarm sweatings called hyperhidrosis.

Today the FDA approved it for the prophylaxis of chronic migraine.The approval for chronic migraine was based on results of the phase 3 Research Evaluating Migraine Prophylaxis Therapy (PREEMPT) program, which was made up of 2 double-blind, placebo-controlled clinical trials that included 1384 adults from 122 centers in North America and Europe, a statement from Allergan notes.

The study showed that the number of days respectively hours in patients suffering from migraine has been significantly reduced. 2 % of the treated patients had side effect and adverse reactions against the material.

Source: Medscape Medical News
Author: Susan Jeffrey

Link to article

Back



DeutschOther
Language


Trainings & Workshops



(click on image)


Congress Lectures by NETWORK Members


Contact Journalists

Dirk Brandl

phone
+49-2508-21 59-100

email brandl@network-

globalhealth.com


Cultural Links



You are interested in photography as an art?

Enjoy yourself at Lightworks Gallery.


Cultural Links



You are interested in good music?

Enjoy yourself at Desire Music.


    2005-2016 by Lichtblick GmbH    Impressum